Dutasteride (Topical)

$60.00$80.00 25% OFF
Concentration
≥99% purity
Third-party tested
Ships from the USA
Secure research packaging
ShippingFree on orders $200+

USPS Priority $10 • UPS 2nd Day Air $15 • USPS Express $30

FulfillmentEstimated 2–5 business days

Tracking is provided when the order ships.

Review return policy →

Restricted to laboratory and analytical research

Products in this catalog are supplied as research materials only. They are not drugs, foods, cosmetics, supplements, or medical devices and are not intended to diagnose, treat, cure, or prevent disease.

Compound overview

Product specifications, research context, and handling information.

Topical Dutasteride — 60 mL

Dutasteride is a synthetic 4-azasteroid supplied here as a liquid research solution in an ethanol and USP propylene glycol vehicle.

Key Research Areas

  • Type 1 and type 2 5-alpha-reductase inhibition
  • Testosterone conversion to dihydrotestosterone (DHT)
  • Androgen signaling in follicular models
  • Solution and vehicle comparisons

Mechanism of Interest

Dutasteride inhibits type 1 and type 2 5-alpha-reductase, the enzymes that convert testosterone to DHT. Its mechanism acts at the level of DHT synthesis. Dutasteride pharmacology reference

Product Details

Format: Liquid solution, 60 mL bottle
Compound: Dutasteride
Compound class: Synthetic 4-azasteroid, dual 5-alpha-reductase inhibitor

0.1% w/v

Dutasteride: 1 mg/mL (60 mg per bottle)

0.3% w/v

Dutasteride: 3 mg/mL (180 mg per bottle)

Vehicle and volume for both strengths

Ethanol: 40 mL (66.67% v/v)
USP propylene glycol: 20 mL (33.33% v/v)
Target final volume: 60 mL

Published Research and Formulation Limits

The 2025 randomized Phase II trial evaluated direct scalp application of dutasteride solutions at 0.01%, 0.02%, and 0.05% w/v (0.1, 0.2, and 0.5 mg/mL). The 0.1% and 0.3% formulations listed here are two and six times the highest concentration tested, respectively. The trial does not establish safety, efficacy, or absorption for either listed formulation. Panuganti et al., 2025 Phase II trial

A separate randomized placebo-controlled study evaluated topical dutasteride alongside microneedling. Its findings apply to the combined intervention and do not establish the effects of conventional topical application alone. Sánchez-Meza et al., 2022 microneedling study

The literature review discusses delivery approaches and the role of the vehicle in skin penetration. Topical dutasteride literature review

Research Use Only

For laboratory research only. Not for human consumption, medical, diagnostic, or therapeutic use.